Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Obesity Research Institute is a private U.S. consumer health company best known for marketing the weight-management supplement brand Lipozene directly to consumers. Available evidence indicates it operates as an active California limited liability company rather than as a drug-development biotech or pharmaceutical company. Its business appears focused on commercialized nutritional or wellness products for weight management, with Lipozene as the primary identifiable brand. Publicly available information does not indicate a traditional biopharma R&D pipeline, clinical-stage therapeutic portfolio, or proprietary therapeutic platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Obesity Research Institute.